Australia's largest stock trading and investment forum Australia's #1 stock forum

PAR

5.00%

19.0¢ paradigm biopharmaceuticals limited..

The Flex?, page-7

First 7 Last

Share
Profile

Follow
Mangoman605

1,647 Posts.

174

19/08/24

21:24

Post #: 75276121
Share

Originally posted by Mozzarc: ↑

A goods evening to you Mangoman,

Nah it's not just you, like some over ripened mangoes, some of these HC images tend to go off after some time, I've complained about it numerous times to HC admin to no avail.

I think this is the table you are referring to:

From an uptake point of view we don't need to have only "Drugs works great" kinda feedback.

Those with a "Little better" will also still generally be happy as their pain and loss of function will usually get worse as OA continues it's destructive path over time.

The current std is so poor that many will simply try iPPS and again, we only need a small fraction of the OA population for us to have a Blockbuster on our hands. Leave aside all the Pain but NON OA conditions this thing is going to be applied to in the future.

The other aspect to the above is the incredible PGIC figures we have already achieved in the well controlled double blinded studies . This is the patient's impression of pain and more and more the insurers and authorities are taking it into consideration.

Here is an example in our 005 and 008 studies where n was only 56 and 15 in the respective active groups:

To get the below anemic p values when n is so low is amazing.

005:

008:

The miniscule p values in such low n numbers means the drug simply works for the patient. This is their impression. What I want to see is what are these sorts of values when n is actually 195.

DYOR

Expand

Thanks Mozz.

PAR Price at posting: 23.0¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

STK

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

ESR

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KAL

KalGold rolls out detailed aeromagnetic survey across Pinjin project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NAM

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

DEG

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

First 7 Last

Add PAR (ASX) to my watchlist

(20min delay)
Last 19.0¢		Change -0.010(5.00%)		Mkt cap ! $66.54M

Open	High	Low	Value	Volume
20.0¢	21.0¢	19.0¢	$203.4K	1.019M

Buyers (Bids)

No.	Vol.	Price($)
14	387930	19.0¢

Sellers (Offers)

Price($)	Vol.	No.
20.5¢	65468	2

View Market Depth

No.	Vol.	Price($)
13	384246	0.190
3	57000	0.185
8	194873	0.180
6	140904	0.175
7	595605	0.170

Price($)	Vol.	No.
0.205	65468	2
0.210	25992	3
0.215	30000	1
0.220	27066	4
0.225	21604	2

Last trade - 16.10pm 27/09/2024 (20 minute delay)

PAR (ASX) Chart

The Flex?, page-7

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

The Flex?, page-7

Top Stories

The market's shrugged at China's stimulus measures all year. Why is this one different?

5.6g/t gold intercept at Serbia's Rogozna supports Strickland's hopes for high-grade core

Estrella first foreign entity to win tenements in Timor-Leste under new laws ahead of 2025 tenders

KalGold rolls out detailed aeromagnetic survey across Pinjin project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACCC seeks Olam divestments before it can buy Namoi Cotton

Week 39 Wrap: What HotCopper’s watching; China’s new stimmy moves boost metals; Oz CPI drop

The winners & losers on market if negative gearing were gone

HotCopper users muse on De Grey's denial of Agnico Eagle takeover bid – but who are Agnico?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News